CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		20,027,065
Beginning balance at Dec. 31, 2022	$ 63,306	$ 20	$ 733,437	$ (670,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and warrants (in shares)		523,329
Issuance of common stock and warrants	867	$ 1	866
Vesting of restricted stock units (in shares)		186,218
Vesting of restricted stock units	0
5-Year Private Warrants transferred to 5-Year Public Warrants	585		585
Stock-based compensation costs	2,922		2,922
Net loss	(55,024)			(55,024)
Ending balance (in shares) at Dec. 31, 2023		20,736,612
Ending balance at Dec. 31, 2023	12,656	$ 21	737,810	(725,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and warrants (in shares)		3,821,362
Issuance of common stock and warrants	12,193	$ 0	12,188	5
Vesting of restricted stock units (in shares)		317,613
Vesting of restricted stock units	0
5-Year Private Warrants transferred to 5-Year Public Warrants	5		5
Stock-based compensation costs	2,627		2,627
Net loss	(60,896)			(60,896)
Ending balance (in shares) at Dec. 31, 2024		24,875,587
Ending balance at Dec. 31, 2024	$ (33,415)	$ 21	$ 752,630	$ (786,066)